Berquist Thomas sold $104K of QLYS

Berquist Thomas sold 939 shares of QUALYS, INC. (QLYS) at $110.75 ($0.10M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Berquist Thomas
Published Jun 15, 2026, 8:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QLYS
Neutral
high confidence
Mentioned
$QLYS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QLYSNeutralLow
01

Why it matters

A director’s open-market sale under a pre-arranged 10b5-1 plan is generally treated as routine compliance rather than a new fundamental catalyst.

02

Market read

Traders may note the filing for positioning/sentiment, but there is no new company-specific information to drive repricing.

03

What to watch

The article provides only the sale size and plan type; it doesn’t indicate whether other insiders bought, whether the sale was tax-related, or whether there were concurrent operational updates.

Relevance 3/10Novelty 2/10Timing: SEC Form 4 filed today (2026-06-15) disclosing a 2026-06-12 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Qualys, Inc.

Company-level read

Ticker impact

$QLYSNeutralHigh confidence
Context

Qualys Form 4 shows director Berquist Thomas sold 939 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and short-lived.

Evidence & confidence

The filing is an insider sale (not a buy), explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific operational or guidance change.

Market effects

No sector read-through; this is a single-company insider transaction without new regulatory/product/earnings information.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with private views on valuation or liquidity needs; traders may still watch for follow-on selling.

Key entities

  • QUALYS, INC.

    Company whose shares were sold by a director via an open-market transaction under a 10b5-1 plan.

  • Berquist Thomas

    Director who sold 939 shares at $110.75/share; holdings after sale were 6,781 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QLYSMed

Qualys Shares Climb 9% On Expanded Cognizant Alliance

Qualys (QLYS) shares rose 9% after announcing an expanded alliance with Cognizant (CTSH). The stock traded at $189.91, up from $177.68. The partnership combines Cognizant's Cyber Vulnerability Management with Qualys' TruRisk Management for AI-powered cyber risk services.

$QLYSHighAI 8/10

Qualys Earnings Call Highlights Growth and Automation

Qualys (QLYS) reported Q3 revenue of $188M, up 11% YoY, with adjusted EBITDA at $89.9M (48% margin). The company raised 2026 revenue guidance to $736.9M-$738.9M (10% growth). Key growth drivers include autonomous remediation, large customer momentum, and federal wins. However, concerns include flat expansion, higher expenses, and softer Q4 billings outlook.

$QLYSHigh

Why is Qualys stock tumbling today?

Qualys (QLYS) stock fell 10.5% after reporting Q3 earnings that beat estimates but provided weaker-than-expected Q4 billings growth guidance. The company reported adjusted EPS of $2.12 and revenue of $188M, up 11% YoY. Analysts responded with cautious notes, adjusting price targets downward. The broader market and cybersecurity sector also declined, but Qualys underperformed due to its guidance miss.